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CHAPTER I 
INTRODUCTION 
studies of the cachectical conditions such as 
anorexia, weight loss, and MUscular weakness observed 
in cancer-bearing animals had long suggested that can-
cer tissues possibly produced some toxic substance. 
The demonstration ot such a substance, however, re-
quired an adequate criterion tor its assay. The dis-
closure ot depressions ot liver catalase activity in 
all cancer-bearing animals provided a criterion. 
By measuring the liver catalase activity in 
laboratory animals injected with a protein traction 
extracted trom malignant tissue it was shown that this 
extract produced a signiticant decrease in catalase 
activity. The substance responsible tor this effect 
was called "toxohormone". 
Further investigations disclosed that additional 
systemic changes such as decreased plasma iron, kid-
ney catalase, and hemoglobin present in cancer-bearing 
animals could be induced in normal animals by the 
injection of toxohormone-containlng tumor fractions. 
Of these the decrease of blood plasma iron appeared to 
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be the most sensitive to the effects 01' toxohormone 
and therefore a possible valuable aid tor further 
experimentation. 
Although research on toxohormone has included 
attempts at purification and investigations relating 
to mode 01' action, no specific research has been di-
rected toward a comparison 01' the toxohor.mone con-
tent 01' malignant tissues. Variations in the activi-
ties 01' different sa~ples of similarly prepared 
toxohormone-containing material have been indirectly 
demonstrated, but whether the variations are due to 
differences in the toxohormone content among different 
types of tumors or cancerous tissues ot varying de-
grees 01' malignancy are hypotheses which have not 
been investigated. In an attempt to determine it there 
1s a relation between degree ot malignancy and the 
toxohormone content 01' malignant tissue, the effect 
of injected toxohormone, extracted from human malig-
nant neoplasms, on blood plasma iron concentration was 
studied in mice. 
CHAPTER II 
REVIh~ OF LITERATURE 
A. Enzymatic Tumor-Host Relations and I~pothesis of 
a Cancer Toxin 
Blumenthal and Brahn (1910) and Brahn (1916) 
reported that the liver cB.talase activity of cancer-
bearing patients was "remarkably low" as compared with 
that of patients with other diseases. Similar results 
were obtained by Rosenthal (1912) during his stUdies 
on tumor-bearing animals, and he hypothesized that 
some toxic SUbstance might be produced in tumor tissues 
to decrease the liver catalase activity. 
Buckley (1921) stated in his text on cancer 
that an abnormal hormonal secretion of cancer cells 
exerted an adverse influence on the body systems be-
cause he had observed that the "condition" of the 
blood was found to be improved temporarily after th~ 
surgical removal of a cancerous mass. 
It was conclusively demonstrated by Greenstein 
and co-workers (Greenstein, Jenrette, and White, 1941; 
Greenstein and Andervont, 1942, 1943) that the liver 
catalase activity of cancer-bearing animals was signi-
ficantly lower than that of normal animals and 
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specifically attributable to the presence of a growing 
tumor and not to any secondary cause to which the 
tumor's presence may give rise. In these articles 
Greenstein et ale reported the following: the activity 
of catalase was by far the most affected ot all the 
individual enzyme systems studied in the livers of 
mice and rats with a wide variety ot malignant tumors, 
the decrease in liver catalase activity was progres-
sive with growth of the tumor, the effect of the tu-
mor upon the activity of this liver enzyme was found 
to be reversible upon removal of the tumor, the de-
crease was due only to the tumor and not to any grow-
ing tissues present in the animal, and the decrease 
was always present in cancer-bearing animals. These 
observations subsequently led Greenstein (1947) to 
state that a tumor may produce the systemic effects 
noted by giving off same toxic product to the circu-
lation. 
B. Toxohor.mone 
1. Discovery and FUndamental Characteristics 
In 1948 Nakahara and Fukuoka, using liver cata-
lase activity as a criterion for bio-assay, demon-
strated that a substance which was extracted from 
human cancerous tissue with water and then prebipitated 
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with alcohol after removing heat-coagulable material 
was capable of significantly decreasing liver cata-
lase activity beyond the normal limits of variability 
after twenty-four hours when injected into mice. In-
jections of fifty to one hundred milligrams of the 
sUbstance produced an average depressed liver cata-
lase activity, expressed in cubiC centimeters of 
oxygen liberated from hydrogen peroxide, of 4.3. Nor-
mal mice were found to have an average liver catalase 
activity of 8.0. Positive results were obtained from 
all malignant tissues used, carcinoma as well as sar-
coma, primary as well as secondary or metastatic, and 
surgical as well as autopsy materials; it was clearly 
distinguishable from similarly prepared fractions of 
normal tissues and normal tissue necrosates which had 
no special depressing effect on liver catalase activ-
ity !a!!!2 (the average activity was found to be 
between 7.2 and 7.5 cubiC centimeters of oxygen after 
injections of these fractions); and it exhibited no 
inhibiting action on crystalline catalase !B vitro. 
The substance was called "toxohorm.one" by the inves-
tigators to express its supposed biological status 
of being a cell-produced substance which is released 
into circulation and which produoes a olearly definable 
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biochemlcal lesion in a target orgs.n. They conceived 
o~ it as being the pathological counterpart o~ hor-
mones. Variations demonstrated in the activities or 
dif'f'erent samples or trle extrB.cted material led 
Nakahara to hypothesize that there might be a relation 
between histological character and toxohormone con-
tent of malignant tissue, but he was unable to demon-
strate this supposition. 
The original work done by Nakahara and Fukuoka 
wa.s confirmed and substantiated by Gree ntield and 
Meister (19$1). It was also shown by these authors 
that ~ractions ~rom the necrotic and non-necrotic 
areas o~ a malignancy produced reductions of' liver 
catalase activity o~ about the same magnitude in mice 
(between a 40 and a 4l~ per cent reduction rrom nor. 
mal). 
Endo at &1. (1955) demonstrated that toxohor-
mone and a substance extracted ~rom malignant tissue 
by Hargreaves and Deutsch (1952) which inhibited 
liver ca.talase activity in vitro but not in vivo 
- --
(the Kochsaft f'actor) were entirely different entities 
since toxohormone inhibited liver catalase activity 
in vivo but not in vitro. 
-- - ................... 
It has been demonstrated by investigators that 
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"toxohormone fractions" prepared from samples of nor-
mal tissues such as liver, spleen, kidney, and whole 
skinned animal homogenates produce very little if any 
decrease in liver catalase activity (Greenfield and 
Meister, 1951; Nakagawa, Kosuge, and Tokunaka, 1955; 
Kampschmidt, Adams, and McCoy, 1959; Fujii, Rawachi, 
Okuda, Haga, and Yaroatuura, 1960). 
As stated by Nakahara and Fukuoka (1958), in a 
review of related literature, all the malignant tumors 
which have been tested, human and animal, have yielded 
a liver catalase-depressing fraction (toxohormone). 
This is in direct accord with the fact that signif-
icantly decreased liver catalase activity has been 
found in all animals bearing malignant tumors. The 
following is a list of the tumors which have been 
investigated: human carcinomas of the stomach, rectum, 
colon, bladder, and breast; human lymphosarcoma; 
human mammary fibrosarcoma; mouse marrnnary sarcoma; rat 
fibrosarcoma; Brown-Pearce carcinoma; chicken sar-
coma; human hepatoma; rhodamine sarcoma, and Walker 
carcinosarcoma. 
Paralleling experimentation on toxohormone, 
Adams (1950, 1951) found that injections of whole 
homogenates of both mouse sarcoma and carcinoma pro-
-7-
duced depressions of liver catalase in mice, and he 
inferred that the depression was due to the release 
of toxic material from the injected tumor homogenates. 
He also demonstrated that the injection ot homo-
genates of a variety ot no~~al tissues produced no 
;' 
significant catalase depressions. Lucke at al. 
(19$2), using parabiotic rats, showed that the liver 
catalase activity in the non-tUMor-bearing partner 
in the parabiotic union was reduoed to the level ot 
single rats bearing the tumor, and he interred that 
a humoral transmission ot some agent from the turrl,o:r 
was responsible. 
Further evidence in support ot the validity 
at the liver catalase-depressing factor 01' Nakahara 
and Fulruoka has bef~n demonstrated by other investi-
gators. Kamp8c~~idt et 81. (1959) reported that 
injections ot one hundred milligrams of an alcoho1-
precipitable extract ot Walker carcinosarcoma 256 
depressed the liver catalase activity ot rats aftar 
twenty-tour hours tram a normal level ot 5400 cata-
lase units to 3150 catalase units. Fujii et al. 
(1960) reported that injections ot twenty milligrams 
ot a plcric8.cid-hydrochloric acld-alcohol-Prec1pltable 
extract ot both human hepatoma and rhodamine sarcoma 
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reduced the liver catalase activity of mice approx-
tmately fifty and sixty per cent respectively. 
2. Purification 
Although some research has been done on the 
purification of toxohormone (Nakahara and Fukuoka, 
1950, 1954; Fukuoka and Nakahara, 1953; Nakagawa, 
Kosuge, and Tokunaka, 1955; Ono, Sugimura, and Umeda, 
1955, 1956), the precise chemical nature of taxo-
hormone has not yet been elucidated. Nakahara and 
Fukuoka (1958), in a summation of the present con-
cepts, state that in its elementary form it is prob-
ably a polypeptide of rather small molecular size. 
It probably occurs in cancerous tissue either as 
aggregates of the elementary form or in close associa-
tion with some other substance, possibly nucleic 
acid; it occurs in both a dialyzable and non-dialyzable 
form, the former being derived from the latter when 
digested with papain or pepsin. The enzymatic action 
which yields the dialyzable form may simply disso-
ciate the nucleic acid from the elementary fo~. 
3. Mode of Action 
The mode of action of toxohormone has also come 
under the investigation of researchers (Fukuoka and 
Nakahara, 1951, 1953; Ono, Umeda, and Sugimura, 1956; 
-9-
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Ono, Ohashi, Bnd Yago, 1960). Nakahara (1960) has 
stated th~t the outstanding changes observed in 
eEl.ncer-bearing animals seem to be specifically related 
to disturbances in iron metabolism, and these changes 
have been elucidated in normal animals by the injec-
tion of toxohormone-containlng tumor fractions (Nakahara 
and Fukuoka, 1949; Greenfield and Meister, 1951; Ono, 
Umeda, and Rugimura, 1956; Roshlz1ma, 1957; Kampschmidt, 
Adams, and McCoy, 1959; Fujii, Kawachi, Okuda, Haga, 
and Yamamura, 1960). He suggests that the production 
of decreased liver catalase activity, increased liver 
protoporphyrin" and decreased liver ferritin and 
blood plasma iron by injections of toxohormone as 
described in these articles are closely related phe ... 
nomena and as such speak strongly for the implication 
of toxohor.roone in the disturbed iron metabolism of 
cancer-bearing animals. 
other changes present in cancer-bearing animals 
and brought about by injections 01' the active tumor 
traction (toxohormone) but not related to iron metab. 
olism have been observed. Fukuoka (1952) demonstrated 
thymus involution in toxohormone-injeeted anL~alsJ and 
Ono (19$9) demonstrated the depression of diphospho-
pyridine nucleotide synthesis in the liver of injected 
-11-
animals. 
C. Tumors, Toxohormone, and Blood Plasma Iron Relations 
One ot the .first reports in the literature 
concerning the relationship of tumors and blood plasma 
iron concentration was that at Hei1meyer and Plotner 
(1937) who reported that the plasma iron level in 
cancer-bearing animals was "low". 
Postiglione (1946). Yanagisawa (19S5), and 
11jima (1956) all repopted that the plasma iron con-
centration in caneer patients was considerably de-
creased (Sugtmura, 19S7). 
Sugimura (19S7), investigating the distribu-
tion ot radioaotive iron inJeoted into tumor-bearing 
rats, noted that the concentration at iron in the 
plasma ot theae anbnals was decreased approxtmatel~ 
,30 per cent. 
Kam'Psc~JMldt at ale (1959) reported that I~ 
jactions at toxohormone-contaln1ng material produced 
a pathological alteration in the blood plasma iron 
concentration ot rats. The iron level was reduced 
from an average normal concentration of 281 ltlicrograms 
per one hundred mIlliliters to an average of eighty-1'Dur 
micrograms per one hundred millIliters e1ght hours 
after single injections of 0.10 milligrams of an 
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alcohol-preoipitable extract ot Walker oaroinosarooma 
2$6 prepared after the method of Nakagawa et ale (1955). 
Injeotions of one hundred milligrams of the same 
material produoed a reduction from an average plasma 
iron oonoentration of 294 miorograms per one hundred 
milliliters to sixty-two miorograms per one hundred 
milliliters after twenty-four hours. This same study 
revealed plasma iron to be 250-500 times as sensitive 
to toxohormone as liver oatalase. 
Fujii et a1. (1960) showed that the plasma iron 
level of rats was signifioantly reduoed from an 
average ot ninety-three micrograms per one hundred 
milliliters to an average of approx~nately fifty 
micrograms per one hundred milliliters within twelve 
hours following intraperitoneal injections of five 
milligrams of toxohormone-oontaining material (piorio 
aoid.hydrooh1oric aoid-alcoho1 precipitate) extracted 
from human hepatoma. 
CHAPTER III 
MATERIALS AND MRL'HODS 
A. Preparation and Injection of Tumor Fractions 
Frozen biopsy specimens of seven malignant 
neoplasms were obtained from Cook County Hospital, 
Chicago, Illinois. They consisted of the following 
tumors as determined through histological examination 
by members of the Department of Pathology of that 
hospital: one adenocarcinoma, rectum; four adeno-
carcinomas, colon; one adenocarcinoma, breast; and 
one anaplastic carcinoma, bronchiogenic. The turaor 
samples were maintained in a frozen state until they 
were homogenized. 
Homogenization and extraction or fat from each 
of the seven tumor specimens was accomplished similar-
ly to the method 01' Fujii et ale (1960). No attetapt 
was made to further purify the remaining material 
by reprecipitatlon since it had been demonstrated by 
other investigators that plasma iron concentration is 
very sensitive to small amounts of to:X:ohorrllone, and 
it was relt that even small amounts ot' this crude 
toxohormone-containing material would depress mouse 
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plasma iron concentration enough so that ~dequate 
comparisons could be :made. The method used is out-
lined as follows: 
1) Approxtmately two grams ot frozen tumor 
tissue was homogenized with approxhnately 
ten volumes ot acetone in a Potter-Elvehjem 
homogenizer suspended in an ice-water bath 
to minimize frictional heating ot the 
sample. 
2) The suspension obtained was oentrituged 
at tive thouaand R.P.M. tor ten minutes 
and the tat-containing supernatant decanted 
and discarded. 
) The protein-containing precipitate was 
washed with acetone, dried in air, and 
preserved in a freezer until needed tor 
injection. 
EXpertmental animals employed in all instances 
were young male albino mice at a homogeneous strain 
weighing approximately twenty to twenty-tive grams. 
Upon reoeipt they were transterred to standard mouse 
cages and maintained on a diet ot Wayne Lab-Blex and 
adequate water supply. In most instances the antmals 
were allowed to remain at least two and not more than 
ten days in their cages before experimentation. Their 
weight was found not to vary more than plus or minus 
three grams during their repository period. 
At the time of injection, one hundred milli-
grams of the dried tumor fraction, containing the 
total protein component, were mixed with 2.5 milli-
liters of 0.9 per cent sodium chloride solution. 
Employing a two cubic centimeter tuberculin syringe 
armed with a twenty-five gauge needle, 0.5 of a mil-
liliter of the saline-tumor fraction suspension, con-
taining twenty milligrams of the tumor fraction, was 
injected intraperitoneally into each of five mice. 
The injected mice were maintained in a normal 
environment on the pre-injection diet and, by pooling 
plasma, two determinations of the collective blood 
plasma iron concentration made twenty-four hours after 
injection (Table VII). 
All seven tumor specimens were tested utilizing 
seven groups of five mice per group. 
B. Blood Plasma Iron Dete~ination 
The method employed for the detennination of 
blood plasma iron concentration was derived from the 
method ot Kitzes, Elvehjem, and Schuette (1944). 
Neither their method nor any other method reviewed 
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(Barkan and Walker, 1940; Peters, Giovanniello, Apt, 
and Ross, 1956) could in entirety be used for plasma 
iron determination in mice since the vol~~le of plasma 
required in these procedures (2.5 mI.) could not bo 
obtained from any one mouse, the initially intended 
number to be used per determination, or consistently 
from groups of five mice, the number finally employed 
in this investigation. The amount of plasma that 
could be obtained from anyone mouse varied from 
0.2 to 0.7 of a milliliter. Volumes below 0.6 of a 
milliliter were obtained 80 per cent of the time. 
Initially, as mentioned above, plasma iron 
determinations were attempted on Single normal mice, 
but sufficient plasma volumes necessary for the adopted 
method could not be consistently obtained. Furtller-
more, the results showed a fluctuation in the nor.mal 
range of values so extensive as to prevent any suitable 
comparisons among single mice (Table V). Because 
of these reasons, plasma was pooled in equal volumes 
from each of five mice for every determination of 
blood plasma iron, thereby insuring a sufficient plasma 
volume and decreaSing the standard deviation. No 
more than five mice per group could be used because 
of the limited amount of tunlor tissue available. The 
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procedure is outlined as follows: 
1) By means of cardiac puncture, approxtmate1y 
one rol. of blood was obtained from each of 
five mice, lightly anesthetized with ether. 
A twenty-five gauge needle was used on a ten 
cubic centimeter glass syringe coated with 
a solution of 0.1 molar sodium oxalate. 
The blood samples were transferred to five 
five-milliliter semi-micro centrifuge tubes, 
respectively. 
2) The oxa1ated blood samples were centrifuged 
at 1550 R.P.M. tor ten minutes. 
3) The plasma was separated from the blood cells 
by means ot a dro~per pipette. One-tenth 
of a m1. was obtained trom each ot the five 
plasma samples and transferred to another 
tive ml. semi-micro centrifuge tube. 
4) Two-tenths of a m1. of distilled water was 
added to the 0.5 of a mae of pooled plasma 
and the tube was placed in boiling water 
tor two minutes. 
5) Two-tenths ot a m1. ot 25 per cent tri-
chloroacetic acid was then added, the 
mixture stirred thoroughly and centrifuged 
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at 1550 R. P.l'1. for ten minutes. 
6) The clear protein-tree supernatant was de-
canted into a tive ml. graduated test tube 
and the volume was noted. 
7) 01stilled water was added to the 1'I·ec1p1-
tate in an amount equal to the d:U"ference 
between the noted volume 01' the supernatant 
and 1.2 rol. The precipitate was broken up, 
stirred well, and the tube was centl"1.tuged 
at 1550 R.P.M. tor ten minutes. 
8) The roeeultant supezanatant was decanted into 
the previous supernatant and distIlled 
water added, it necessary, to make 1.2 ml. 
9) The following were added to the tube Con-
taIning the clear supernatants: 
a) 0.05 01' a ml. 01' undIluted thioglycolic 
acid 
b) O.os 01' a ml. at 5 per cent a,a '-dipyrldyl 
c) 0.2 01' a m1. of 25 nor cent sodium citrate 
The contents were mixed. 
10) The resultant 1.5 mI. pink solution was 
transterored to a microcuvette, and after 
tifteen minutes its absorbance at 508 mp 
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was roead on a Beckman Junior Spectrophotonleter 
which had been adjusted to the zero reading . 
with distilled water. 
11) The concentration of blood plasma iron was 
calculated by using a previously prepared 
standard curve which plotted concentration 
of iron against absorbance (Figure 2). The 
actual value as obtained from the graph 
was multiplied by a factor of two since only 
0.5 of a ml. ot plasma was used, and the 
graph was based on values obtained from one 
mI. ot standard iron solutions. 
Two dete~inations were run on each sample of 
pooled plasma. 
The reagents were tested for each group of 
determinations made by performing a determination on 
a known iron concentration and comparing the result 
with an originally obtained value. 
Co-ordinates used in the preparation of the 
standard iron curve were obtained by averaging the 
absorbance readings obtained fram three determinations 
performed on an iron-free solution and each of the 
following six iron concentrations derived fram a 
standard iron solution: 30, 60, 90, 120, 180, and 
240 micrograms per one hundred milliliters (Table I). 
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The concentration rL~e was adopted fram nor-mal rat 
plasma iron levels as reported by Kampschmidt at a1. 
(19$9). Jete:rminationa were run in the following 
manner: 
1) Two-tenths of a ml. of 25 per cent tr1-
chloroacetic aoid, 0.05 of a ml. of ~~­
diluted thiog1yoollc acId, 0.05 of a ml. 
of $ per cent a,a'-dipyridyl, and 0.2 of 
a ml. ot 25 per cent sodium citrate were 
added to one rul. of distilled water con-
taining a known oonoentration of Iron. 
2) The resultant 1.$ ml. solution was trans-
ferred to a microcuvette and after fifteen 
minutes its absorbance at SO~ mp was read 
on a Beckman Junior 3pectrophotatlleter 
which had been ad3usted to the zero reading 
with distilled vater. 
The equation ~or the linear curve used in plot-
ting conoentration against absorbance was calculated 
from the statistical method ot "least squares It (Batson, 
1960) (Figure 1). 
Normal blood plasma iron ooncentration and 
standard deviation were obtained by performing the 
afor$mont1oned plasma iron determination on seven 
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groups of five mice per group. averaging the results, 
and applying a standard statistical method for de-
termining standard deviation (Page and Culver, 1961) 
(Table VI). 
The precision and accuracy of the adopted 
method was determined and evaluated for the standard 
iron solutions and plasma by recovery experiments 
and by experiments dealing with reproducibility of 
results (Tables II, III, and IV). 
C. Determination of .Degree of lJfalignancy 
Histological sections prepared from the tumor 
specimens used were obtained from Cook County Hospital, 
and a comparison of the degree of malignancy of each 
of the seven tumors was made using the histopatho-
logical characteristics ot: anaplasia, increased 
number of mitotic figures, nuclear hyperchromatism 
and increased nucleocytoplasm ratio, and loss of cell 
polarity. Each of the four histopathological char-
acteristics were assigned values fram one to three; 
three being the number used to indicate the greatest 
relative anaplasia, nuolear hyperchromatism and size, 
number of mitotic figures, or loss of polarity in 
relation to the other neoplasms. The mitotic index 
was determined by counting the number of mitotic 
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figures in ten high power fields. The tumors which 
had the greatest sum total of values were considered 
to be the most malignant (Boyd, 1953) (Table VIII). 
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OHAPTER IV 
FINDINGS 
The findings have been placed in chronological 
order as an aid to understanding the investigative 
process used to arrive at the conclusions presented. 
The yield of dried precipitates obtained from 
the extraction of the protein component of approx-
imately two grams of each of the seven tumors em-
ployed varied in weight from 115 to 200 milligrams. 
Table I lists the average and individual ab-
sorbance figures obtained fram colorimetric deter-
minations performed on known iron concentrations and 
an iron-free solution. The range of absorbance 
values,.018 through .180, was of necessity low and 
narrow since the related iron concentrati.on range 
desired, zero through 240 micrograms per one hundred 
milliliters, was similarly characterized. However, 
even in this range it was found that readings could 
be made quite accurately on the Beckman Junior Spec-
trophot ometer. 
The co-ordinates used in the preparation of 
the standard iron curve were obtained fram the 
-23-
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TABLE I 
ABSORBANCE READINGS OF KNOWN IRON 
CONCENTRATIONS 
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TABLE I 
meg./100 1111. A1 A2 A3 A Average 
0 .017 .019 .018 .018 
30 .0~3 .041 .044 .043 60 .0 1 .065 .060 .062 
90 .083 .080 .077 .080 
120* .099 
180 .139 .138 .1~O .139 240 .180 .175 .1 5 .180 
*See Table II 
figures presented in Table I: the!. component was 
given absorbance values, and the Z component was 
given concentration values. The plotted points in-
dicated a linear curve, and the statistical equation 
shown in figure 1 was used to calculate the straight 
line. Figure 2 is a representation of the standard 
iron curve used. The curve does not origina.te at 
zero since the spectrophotometer was adjusted to 
zero with distilled water and the first reading 
made with distilled water plus reagents. 
Since the method used to determine blood plasma 
iron concentration was a new one, tests were run to 
dete~ine its preCision and aocuracy. The preCision 
ot a method depends upon reproducibility of results, 
and in general, the standard deviation of a set of 
values trom a set ot deter.minations upon the s~e 
material 1s a measUl'ement ot the reproducibility ot 
a measurement (Pase and Culver, 1961). The method 
used to determine the standard deViation ot results 
obtained fram a standard iron solution was the per-
formance of absorbance measurements on several 81i-
quota fram that solution and solving the statistical 
equation, (J: YF~::(~ : f12 J. The standard devia-
tion was found to be plus or minus .0028 units 
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EQUATION: 1\ X 
= 
X + b (Y - Y) where: 
1\ X is the expected value of X at a 
given value of Y, 
X is the mean of the observed values 
of X, 
b is the slope of the line computed 
as: LXy where: 
L.y2 
L.xy 
= 
LXY - ( ~X) ( ll) 
n 
Ly2 
-
"2.y2 - ( LY)2 
-
n 
Y is the mean of the given values 
of Y 
A 
21.0 + O.66Y X 
-
-
FIGURE 1. 
STRAIGHT LINE EQUATION 
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240 
200 
160 
meg./IOO ml. 120 
80 
40 
o 
o .020 .060 .100 .180 
ABSORBANCE 
FIGURE 2. 
STANDARD IRON CURVE 
(2.8 adjusted). The coerficient or variation was 
2.8% (Table II). The standard deviation or measure-
ments on plasma was found to be plus or minus 3.46 
and was determined by performing duplicate iron con-
centration measurements on each one of a number of 
plasma speclmens and solving the equation, ~= ,j~~2 
(Table III). In general, the permitted variations 
for clinical chemistry tests are limits or errors 
based on plus or minus 3~or upon a coefficient of 
variation of plus or minus 2-3% (Page and Culver, 
1961). The accuracy of the adopted method was deter-
mined for plasma by the performance of recovery ex-
periments. A known amount of iron was added to 
one-half of a divided plasma sample and the divided 
samples quantitatively analyzed for iron. In this 
manner the percentage of added iron recovered could 
be determined and used to assess the accuracy of the 
method. The average amount recovered was 96.8% as 
shown in Table IV. 
As indicated in Chapter III, determinations 
of pla3ma iron concentration were attempted on single 
mice, but sufficient plasma volumes could not be 
consistently obtained. Furthermore, the dispersion 
of normal values, as measured by standard deViation, 
-28. 
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TABLE II 
REPRODUCIBILITY OF RESULTS USING AN 
IRON SOLUTION 
TABLE II 
Concentration of Iron Solution 
120 mcg./100 ml. 
ALIQUOTS(n) ABSORBANCE(x) 
#1 
#2 
$~ 
#5 
#6 
#7 
#8 
#9 
#10 
#11 
MEAN(x) :: .099 
.097 
.102 
.094 
.097 
.100 
.102 
.100 
.101 
.096 
.102 
.097 
STANDARD DEVIATION! IT) : V r~=!X _ -1 i. )2, J 
tr = ! .0028 
COEFFICIENT OF VARIATION(C.V.) - tr 100% 
--
a.v. :: 2.8% 
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TABLE III 
REPRODUCIBILITY OF RESULTS USING 
PLASMA 
PLASMA SAMPLES(n) 
1 
2 
3 
4 
5 
STANDARD DEVIATION(cr) 
TABLE III 
PLASMA IRON CONCENTRATION 
OF DIVIDED SAMPLES 
mcg./100 ml. 
(a) (b) 
258 
262 
234 
228 
240 
=yL:,2 
254 
258 
238 
222 
246 
where: d : dirference 
between duplicates 
cr :! 3.46 
-30-
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TABLE IV 
RECOVERY OF ADDED IRON 
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TABLE IV 
DIVIDED Fe ADDED Fe FOUND ADDED Fe 
PLASMA SAMPLES meg. meg. RECOVERED - % 
#1 Human a) 0 0.40 
b) 0.9 1.34 104 
-_ ...... _- ......... - ......... _ .......... __ ..... _------ ..... ----
112 Ifuman a) 0 0.58 
b) 0.9 1.44 96 
-- .... '- .. - ...... _---- .... - ......... ---_ .... _- ... -.--
#3 Mouse a) 0 1.05 
b) 0.9 1.90 94 
- ... - ....... --- ...... _-- ... _ .. _ ... _ ... _--------
#4 Mouse a) 0 1.18 
b) 0.9 2.02 93 
... - ... ------- ................... _ .... --------- ...... -
#5 Mouse a) 
b) 
o 
0.9 97 
Average = 96.8% 
was considered too extensive to permit an adequate 
comparison of toxohormone activity utilizing the 
criterion of plasma iron concentration. The mean 
plasma iron level for single normal mice was found 
to be 246 micrograms per one hundred milliliters 
with a standard deviation of plus or minus 21.0 
micrograms (Table V). The standard deviation and 
mean iron concentration of plasma pooled from seven 
groups of five normal mice per group were then de-
termined. The mean was 249 micrograms per one hun-
dred milliliters, and the standard deviation was plus 
or minus 10.63 micrograms which was considered ac-
ceptable for making adequate comparisons (Table VI). 
The injection of twenty milligrams of the 
toxohormone-containing tumor fractions produced no 
apparent visual effects in the mice, nor did any of 
them die prior to the determinations of blood plasma 
iron concentration. As mentioned previously, two 
determinations were made on each sample of pooled 
plasma obtained from five similarly injected mice, 
and the results were averaged. Table VII shows the 
tumors from which the injectable materials were ob-
tained and the average resultant plasma iron concen-
trations which ranged fram 125 to 212 micrograms per 
-32-
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TABLE V 
VALUES, MEAN, AND STANDARD DEVIATION OF PLAS}!I,A IRON 
CONCENTRATION AMONG SINGLE NOm{AL MICE 
MOUSE(n) 
#1 
#2 
~ 
#5 
116 
#7 
#8 
#9 
#10 
#11 
#12 
#13 
TABLE V 
PLASMA IRON CONCENTRATION(x) 
meg./100 ml. 
256 
262 
2)6 
225 
244 
210 
236 
284 
270 
230 
266 
228 
250 
MEAN(i) ': 246 meg./IOO ml. 
STAIIDARD DElTIATION(o-) " vi [ L ~x_ - /12 ] 
tT : ~ 21.0 
COEFF'ICIENT OF VARIATION(C.V.) = (T lOO~ 
-
x 
C.V. : 8.5% 
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TABLE VI 
VALUES, MEAN, AND STANDARD DEVIATION OF THE IRON 
OONCENTRATION OF PLASMA POOLED FROM 
GROUPS OF FIVE NORMAL lUCE 
GROUPS(n) 
1 
2 
3 
~ 6 
7 
TABLE VI 
PLASMA IRON CONCENTRATION(x) 
meg./100 ml. 
236 
252 
240 
264 
~~ 
262 
MEAN(x) = 249 meg.1 100 ml. 
STANDARD DEVIATION( crl : y [ L. ~x _ -1 X f J 
(T :! 10.63 
COEFFICIENT OF VARIATION( C. V .) = r:r 100% 
-
x 
a.v. - 4.2~ 
-
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TABLE VII 
POOLED BLOOD PLASMA IRON CONCENTRATIONS OF 
GROUPS OF FIVE 1-1ICE INJECTED WITH 
TUMOR FRACTIONS 
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TABLE VII 
AVERAGE 
PLASMA IRON CONCENTRATION 
(a) mcg./100 m1. TUMOR (b) Average 
1) Anaplastic 
carcinoma, 
bronchiogenic 
(279-63) 172 116 174 
2) Adenocarcinoma, 
breast 
(6339-63) 200 204 202 
3) Adenocarcinoma, 
colon 
(14187-6,3) 128 122 125 
4) Adenocarcinoma, 
colon 
(9741-63) 164 170 167 
5) Adenocaroinoma, 
oolon 
(8719-63) 208 216 212 
6) Adenocaroinoma, 
reotum 
(6673-6,3 ) 180 174 177 
7) Adenocaroinoma, 
colon 
(282-63) 212 208 210 
one hundred milliliters. 
Periodic testing of the reagents revealed 
them to be stable throughout the investigation and 
capable of giving consistent results. 
To compare the toxohormone activity of the 
seven malignant tumors employed, a granh was prepared 
Which showed the resultant blood plasma iron concen-
trations of seven groups ot tive mice per group in-
jected with the toxohormone-containing tumor tractions. 
The plus or minus 10.63 standard deviation of plasma 
iron concentration obtained trom the groups ot five 
nor.mal mice was utilized in the preparation of the 
graph. This measure of dispersion includes both 
the normal spread of plasma iron values and the in-
herent laboratory errors. The graph depicts three 
distinct and separate groups into which the resultant 
plasma iron concentrations may be divided. The nor-
mal plasma iron concentration was also included for 
comparison (Figure 3). 
A comparison of the degree of malignancy of 
each ot the seven tumors was made. As indicated in 
Chapter III, values fram one to three were assigned 
the four histopathological characteristics utilized; 
three indicating the greatest relative degree ot 
TUMOR 
ADENOCARCINOMA, COLON 
8719-63 
ADENOCARCINOMA, COLON 
282-63 
ADENOCARCINOMA, BREAST 
6339-63 
ADENOCARCINOMA, RECTUN 
6673-63 
ANAPLASTIC CARCINOMA, 
BRONCHIOGENIC 
279-63 
ADENOCARCINOMA, COLON 
9741-63 
ADENOCARCINOMA, COLON 
14187-63 
110 130 
NORMAL PLASl"lA ~ 
IRON CONCENTRATION 
170 190 210 
PLASMA IRON CONCENTRATION 
meg./I00 m1. 
FIGURE 3. 
STANDARD 
DEVIATION 
230 250 
1'mIOR : PLABIA IRON COICEl'fRAtIOB 
malignancy. The sum total of the histopathological 
values was then calculated for each tumor and the 
comparison was made. The adenocarcinoma of the 
breast (6639-63) and the adenocarcinoma of the colon 
(282-63) were found to be the most malignant. Two 
adenocarcinomas of the colon {14l87-63 and 9741-63} 
were found to be the least malignant (Table VIII). 
As mentioned in Chapter III, tumors with the greatest 
sum total of histopathological values were considered 
to be the most malignant, and conversely, tumors with 
the least sum total of values were considered to be 
the least malignant. 
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TABLE VIII 
COMPARISON OF DEGREE OF ~ALIGNANCY 
'* 
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TABLE VIII 
TUMOR A. (M. I. ) l-i. N.H.&S. P. TOTAL 
Adenocarcinoma, (12) breast (6339-63) 3 3 3 3 12 
Adenocarcinoma, 
(13 ) co1on(282.63) 3 3 2 3 11 
Anaplastic carcinoma, (5) bronchIogenic (279.63) 3 1 2 3 9 
Adenocarcinoma colon(8719-63~ 2 (5 ) 1 2 2 7 
Adenocarcinoma, (6 ) rectum(6673-63) 2 1 2 2 7 
Adenocarcinoma, (6) colon(14187·63) 1 1 2 1 5 
Adenocarcinoma colon(9741-63~ 2 (4 ) 1 1 1 5 
A. - Ana'Plasia 
(M.I.) - Mitotic Index 
M. - Number of Mitotic Figures 
N.H.&S. - Nuclear Hyperchromatism and Nucleocytoplasm Ratio 
P. - Loss of Polarity 
CHAPTER V 
DISCUSSION 
The method adopted for the quantitative meas-
urement of iron in small volumes of blood plasma was 
found to be precise, accurate, and reliable for the 
investigation conducted. 
Although the range or dispersion of normal 
plasma iron levels was reduced by pooling blood from 
groups of five twenty-five gram male mice, it is sug-
gested that even larger groups of mice of this weight 
be used to further reduce the standard deviation if 
very precise comparisons of plasma iron values are 
to be made. For this investigation, however, the 
range obtained was suitable for adequate comparisons 
of the plasma iron levels produced by injectable 
tractions extracted from different tumors. 
From results obtained it may be stated that 
intraperitoneal injections of twenty milligrams of 
the similarly prepared total protein-containing 
fractions extracted fram each of the seven human 
malignant tumors tested produced definite decreases 
in the blood plasma iron concentrations of young male 
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mice after twenty-four hours. This is in agreement 
with the results of other investigators who have 
studied the effects of protein-containing tumor 
fractions on blood ~lasma iron concentration 
(Kampschmidt et al., 1959; Fujii et al., 1960; Ono 
at al., 1960). Also in accord with results obtained 
by these investigators is the fact that plasma iron 
appears to be quite sensitive to the substance causing 
its depression since the injection of only twenty 
milligrams of the crude protein-containing fraction 
used in this investigation produced substantial de-
pressions; as much as 50 per cent in one instance, 
although the average was a 30 per cent decrease. How-
ever, this research problem was not specifically 
undertaken to show that a fraction of malignant tissue 
produces unique systemic changes when injected into 
laboratory animals. It has been well demonstrated 
by other investigators that a eharacteristic, toxie, 
protein or prote1n-like substance, called"toxohormone", 
is produced by malignant tissue, and is responsible 
for certain systemic changes, including that of de-
creased blood pla8ma iron concentration, when in-
jected into laboratory animals. This knowledge has 
been used as a premise upon which this investigation 
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was based, and the findings presented which demon-
strate a decrease in the normal plasma iron concen-
tration after injections with malignant tumor frac-
tions serve only to help elucidate this knowledge 
without attempting to prove its veracity. 
Interpretation of the findings, in view of the 
purpose of this research, seam to justify the fol-
lowing conclusions. It the graph presented in figure 
3 is analyzed, it is apparent that the resultant 
decreased plasma iron concentrations, induced in mice 
by similar injections of the protein-containing frac-
tion of malignant tumors, can be divided into three 
distinct groups which are not connected by any limits 
ot the standard deviations. It is therefore possible 
to divide the seven human malignant neoplasms inves-
tigated into three unrelated groups in reference to 
their effect on plasma iron concentration and to 
conclude that various individual tumors among the 
seven produce varying amounts of the substance which 
causes this effect, presumably toxohormone, or that 
the SUbstance produced may be more systemically 
toxic in some instances. Furthermore, if the relative 
degree of malignancy of each of the tumors is compared 
with the related plasma iron depressions induced by 
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them, it p;enerally apnears that or tbe seven human 
malignant neoplasms tested, the most malignant tumors 
produced the least depression or plasma iron, and 
conversely, the least malignant tumors produced the 
greatest depression or plasma iron, (Table IX). If 
the bronchiogenic anaplastic carcinoma is excluded, 
being a different type of tumor than the other six, 
the picture is made even clearer. Thererore it 
would seem that the more malignant a tissue is the 
less toxohormone it produces. Ir this hypothesis is 
viewed in light or Greenstein's (1955) idea that a 
substa.nce which is a toxin In a turnor due to abnormal 
production may only be a normal regulator or metabolic 
processes in normal tissues, it is conceivable that a 
tumor which more closely resembles normal tissue, 
although possessing an exaggerated metabolism, may 
produce greater amounts or this "regulator" (toxo-
hormone) than the tumor with a high degree of malig-
nancy which may be mostly adapted to growth a.nd as 
such has lost or altered its biochemical mechanism 
to produce this "regulator" in large amounts. How-
ever, before this hypothesis could be stated as a 
theory for malignant tissue, greater numbers of the 
same type of malignancy trom the same organ would 
-44-
TABLE IX 
COMPARISON OF RELATIVE DEGREE OF MALIGNANCY 
WITH RELATED PLASMA IRON DEPRESSIONS 
TUMORS 
(Grouped According 
To Graph In Fig. 3) 
Adenocarcinoma. breast(6339-63~ 
Adenocarcinoma" 
colon(282.63) 
Adenocarcinoma, 
colon(8719-63) 
TABLE IX 
AVERAGE 
PLASMA IRON 
CONC. 
mcg./100ml. 
202 
210 
212 
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VALUES DENOTING 
RELATIVE 
DEGREE OF MALIGNANCY 
(From Table VIII) 
. 
12(most malignant) 
11 
7 
-~-~~---~~--~~-~~-~---~-~------
(Anaplastic carcinoma bronchlogenic)(279-63~ 
Adenocarcinoma-t 
rectum(6673-63 ) 
Adenocarcinoma, 
co1on(9741.63) 
(174) (9 ) 
177 7 
167 5 
--------~~---~----~----~~--~-~-
Adenocarcinoma, 
colon(14187·63) 125 5(least malignant) 
have to be compared. In addition, serial sections of 
the tumors should be made for histopathological 
examination since it is possible that a single section 
may not be representative of the whole. In this 
project only six tumors were of the same type of 
malignancy (adenocarcinoma) and only four of these 
were from the same organ (colon). The results ob. 
tained from these four alone demonstrate minimal 
but good evidence for the hypothesis presented. 
No attempt was made to determine the total 
protein content of the various samples of malignancies 
employed since this was considered unnecessary for 
this particular investigation in view of the fact 
that the representative tumor samples were similarly 
prepared and equal amounts of the dried fractions 
injected, and it was not the purpose of this investi-
gation to Compare toxohor.mone content with total 
protein content. 
In relation to this investigation, two other 
questions remain to be answered; is toxohormone 
characterized by different degrees of toxicity, and 
do different types of malignancies produce varying 
amounts of toxohormone or toxohormone of varying 
degrees of toxicity? 
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CHAPT~~ VI 
SUMMARY AND CONCLUSIONS 
An investigation was undertaken to compare 
the toxohormone content ot human malignant tissues. 
The tollowing seven human malignant tumors 
were tested: tour adenocarcinomas, coloni one adeno-
carcinoma, breast; one adenocarcinoma, rectum; and 
one anaplastic carcinoma, bronchiogenic. 
The measurement ot blood plasma iron concen-
tration in mice atter injections ot similarly pre-
pared tractions ot these tumors served 8S the means 
by which comparisons were made. 
Tumor tractions were prenared by homogenizing 
two-gram trozen tumor samples with acetone, centri-
tuging the suspension, and drying the resultant 
precipitate in air atter decanting and discarding 
the supernatant. 
Por each ot the seven malignancies tested, 
twenty milligrams ot the dried protein-containing 
traction were injected intraperitoneally into each 
ot tive twenty-tive gram male albino mice and, by 
pooling plasma, two spectro~hotometric determinations 
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of the collective blood plagma iron concentration 
made twenty-four hours Hfter injection. Groups of 
five mice were utilized to decrease the normal dis-
persion of plasma iron levels and to obtain sufficient 
plasma volumes for the determinations. 
A new spectrophotometric method of determining 
blood plasma iron concentration was developed for this 
study since other methods reviewed required larger 
volurrles of plasma than could be obtained. 
Normal blood plasma iron concentration and 
standard deviation were calculated tor plasma pooled 
from five mice by performing the adopted spectronho-
tometric determination on seven groups of five normal 
mice per group, averaging the results, and applying 
a statistical method for determining standard devia-
tion. 
A comparison of the degree of malignancy of 
each of the seven tumors was made using the histo-
pathological characteristics of: anaplasia, increased 
number of mitotic figures, nuclear hyperchromatism, 
and loss of cell polarity. 
The relative degree of malignancy of each of 
the tumors was compared with the related plasma iron 
depressions induced by their injected fractions. 
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The following conclusions seem to be justified 
on the basis of the results of this study: 
1) The adopted spectrophotometric method of 
blood plasma iron determination appears to 
be precise, accurate, and reliable for 
utilization in this type of investigation. 
2) The average normal blood plasma iron con-
centration of seven groups of five twenty. 
five gram male albino mice is 249 plus or 
minus 10.63 micrograms per one hundred 
milliliters. 
3) The blood plasma iron concentration of groups 
of five young male mice was significantly 
reduced twenty-four hours after single in-
jections of twenty milligrams of similarly 
prepared toxohormone-containing fractions 
extracted from each of the seven human 
malignant tumors tested. Depressed plasma 
iron values ranged from 125 to 212 plus or 
minus 10.63 micrograms per one hundred mil-
liliters. 
4) The plasma iron level of groups of young male 
mice appears to be quite sensitive to the 
effects of injections of even small amounts 
-48 .. 
of crude toxohormone-containing tumor frac-
tions. An average denression of 30 per cent 
was observed. 
5) Various individual malignant tlImOrS among 
the seven tested contained varying amounts 
of toxohormone or toxohormone of varying 
degrees of toxicity. 
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6) It generally appeared that of the seven mal!g-
nant tumors investigated, the more malignant 
a tumor was the less toxohormone (or les8 
toxic) it produced, and conversely, the less 
malignant a tumor was the more toxohormone 
(or more toxic) it produced. 
BIBLIOGRAPHY 
Adams, D. H. "The Mechanism of the Liver Catalase De-
pressing Action of Turnors in Mice," Brit, l..!.. Cancer, 
4: 183, 1950. 
Adams, D. H. "Further Observations on the Liver Cata-
lase Depressing Action of Tumors," Brit. J. Cancer, 
5: 115, 1951. 
Barkan, G., and Walker, B. S. "Determination of Blood 
Plasma Iron," ~ B10l. Chem., 135: 37, 1940. 
Batson, H. C. An Introduction to Statistics in the 
Medical SCiences, Minn.: Iiurgess fublishi~o., 
1960. 
Begg, R. W. tfTumor-Host Relations, n ~ Cancer ~, 
5: 1, 1958. 
Blumenthal, F., and Brahn, B. "Die Katalasewrikung 
in Norm.aler und in Carcinomatoser Leber," ~. 
Krebsforsch, 87: 436, 1910. 
Boyd, William. A Text-Book of Pathology, Philadelphia: 
Lea and Febiger, 19~.-- .. 
Brahn, B. "Weitere Untersuchungen uber Fermente in der 
Leber von Krebskranken, fI .sitzber. ~ preuss. 
Akad. Wiss., 478, 1916. 
Buckley, L. Duncan. Cancer ~ 1l! Non-Surgical Treat-
~, New York: William Wood and Co., 1921. 
Busch, Harris. ~iochemistry ~ !h! Cancer Cell, New 
York: Academic Rress, Inc., 19~2. 
Day, E. D., Gabrielson, F. C., and Lipkind, J. B. 
"Depressions in the Activity of Liver Catalase 
in Mice Injected with Hamogenates of Normal 
Mouse Spleen," J. Natl. Cancer Inst" 15: 365, 
1955. 
-50. 
Endo, H., SUgimura, T., Ono, T., and Konno, K. "Cata_ 
lase Depressing Tissue Factors: Toxohormone and 
Kochsa!'t Factor, t1 Q!!:.m, 46; 51, 1955. 
Fujii, S., Kawachi~ T., Okuda, H., Haga, B., and 
ygmam~a, Y. IThe Isolation of a Basic Protein 
I-Iaving Toxohormone Activity from Tu..'rfior Tissues," 
~, 51: 223, 1960. 
Fukuoka, F., and Nakahara, w. !tHode 01" Action 01" Toxo-
hormone. A ~lird Study on Toxohormone: A Charac-
teristic Toxic Substance Produced by Cancer 
Tissue," Q!!!!, 42: 55, 1951. 
Fukuoka, F., and Nakahara, w. tlToxohormone and Thymus 
Involution in Tumor Bearing Animals. A Fourth 
Study on Toxohormone: A Characteristic Toxic 
Substance ProducAd by Cancer Tissue," Gann, 43: 
55, 1952. 
FUkuoka, F., and Nakahara, W. "Amino Acids and Toxo-
hormone Synthesis. A Firth Study on Toxohormone: 
A Characteristic Toxic Substance Produced by 
Cancer Tissue," Q.!!m, 4l~: 1, 1953. 
Greeni'ie1d, R. E., and Meister, A. "Ef!'ect of Injec-
tions of Tumor Fractions on Liver Catalase Activ-
ity of Mj.ce," It.. ,Nat1. Cancer Inst., 5: 997, 1951. 
Greenstein, Jesse p. Biochemistry of Cancer, New York: 
Academic Press, Inc., 1954. - • 
Greenstein, J. P., and Andervont, H. B. "The Liver 
Catalase Activity of Tumor-Bearing Mice and the 
Effect of Spontaneous Regression and Removal of 
Certain Tumors," J. Natl. Cancer Inet., 2: 345, 
1942. 
Greenstein, J. P., and Andervont, H. B. "Note on the 
Liver Catalase Activity of Pregnant Mice and ot 
IUca Bearing Growing Embryonic Imp1ants," J. 
Nat1. Cancer Inst. 4: 283, 1943. --
Greenstein, J. P., Jenrette, \v. v., and vJr:.ite, J. "The 
IJiver Catalase Activity of TuIrior-Bearing Rats 
and the Effect of Extirpation of the Tumors," lL Natl. Cancer !Dst. 2: 283, 1941. 
-51-
Hargreaves, A. B., and Deutsch, H. F. "The!!! vitro 
Inhibition of Catalase by a Turnor Factor," Cancer 
~, 12; 720, 1952. 
Iiellmeyer, L., and Plotner~ K. "Das Sermeisen und die 
Eisenmange Krankheit, f Fisher. ~, 1937. 
Hoshiziroa, H. "studies on the 11echanism of Toxohormone 
FUnction," ~, 48: 239, 195'9. 
'~ Kampscbm.idt, R. F., Adams, M. E., and !'ICCoy~ T. A. 
"Some Systemic Effects of Toxohormone, I Cancer 
Res., 19:236, 1959. 
-
Kitzes, G., Elvehjem, C. A., and Schuette, H. A. 
"Thei)etermination of Blood Plasma Iron, tf J. 
Biol. phero., 155: 653, 1944. 
/ " Lucke, B., Berwick, M., and Zeckwer, I. T. Liver 
Catalase Activity in Parabiotic Rats with One 
Partner Turnor Bearing, If k Netl. Cancer Inst. 
13: 681, 1952. 
Nakagawa, S., Kosuge, T., and Tokunaka, H. "Purifi-
cation of the Liver Catalase-Reducing Substance 
Occuring in Cancer Tissues, with Special Refer-
ence to Its Activity,·n ~, 46; 585, 1955. 
Nakahara, w. tfA Chemical Basis :for Tumor-Host Rela-
tions," ,J. Uatl, Cancer Inst., 24: 77, 1960. 
Nakahara, W., and Fukuoka, F. "Toxohormolle: .A Charac-
teristic Toxic Substance Produced by Cancer 
f].lissue,t1 ~, 40: 45, 1949. 
Nakahara, W., and Fukuoka, F. "Purification of Toxo-
hormone • .A Second Study on Toxoho~none: A Char-
act~ristic Toxic Substance Produced by Cancer 
Tissue," ~, 41: 47, 1950. 
Nakahara, if/., and Fukuoka, F. "Dialyzable li'orm o:f 
Toxohormone. A Sixth study on Toxohormone: A 
Characteristic Toxic Substance Produced by 
Cancer Tissue," ~, 45: 67, 1954. 
-52-
Nakahara, W., and Fukuoka, F. ItBiosynthesis of.' Toxo-
hormone. A Seventh study on Toxohormone: A 
Characteristic Toxic Substance Produced by 
Cancer Ti ssue, rt Q!!m, 45: 77, 1954. 
Nakahara, W., and Fukuoka, F. "The Newer Concept of.' 
Cancer Toxin," Advances Cancer Res., 5: 157, 1958. 
Nakahara, Waro and Fukuoka. Fum.iko. Chemistrx £! 
Cancer Toxin Toxohormone. Springf.'1eld: Charles 
C. Thomas, 1961. 
Okamura, Y., Fujii, S., Kawachi, T., Kawanami, H., 
Kuwano, lol., and Yamamura, Y. "Eff.'ect of.' Enzyma-
tic Hydrolysis on Toxohormone Activities," Gann, 
53: 365, 1962. 
Ono, T., Ohash1, M., and Yago, N. "The Eff.'ect of.' 
Toxohormone on Iron Metabolism," Gann, 51: 213, 
1960. ----
Ono, T., Sugixnura, T., and Umeda, M. "Preparation 
of.' Potent Concentrates of.' Toxohormone Free f.'rom 
Nucleic Acid," Gann, 46: 617, 1955. 
Ono, T., Sugimura, T., and Urneda, M. "The Purif.'1ca-
tion of.' Toxohormone," ..9:!!!!l, 48: 91, 1956. 
Ono, T., and Tomaru, T. nThe Toxic Tumor Factor 
Depressing DPN Synthesis in Tumor-Bearing Ani-
mals," ~, 50: 37, 1959. 
Ono, T., Umeda, M., and Sugimura, T. "Porphyrin 
Metabolism in Tumor Bearing Animals. Free Por-
phyrin in Liver, Harderian Gland and Urine and 
the Ef'f.'ect Thereon of.' Toxohormone," Q.!.!m, 47: 
171, 1956. 
Page, Lot B., and Culver, Perry J. Laboratory ~­
aminations in Clinical DiagnOSiS, Mass.: Harvard 
UniverSity ~es8, 1961. 
Peters, T., GiOVanniello, T. J., Apt, L., and Ross, 
J. F. "A Simple Improved Method f.'or the Determi-
nation of.' Serum Iron. II," L.. Lab. Clin. Hed., 
48: 274. 1956. 
-53-
Rosenthal, E. "Untersuchungen U'ber Fermente in dar 
Leber und des Blutes bei !'"I.!'ebsmausen, II Dent. 
med. Wochsehr,., 38: 2216, 1912. . .• 
Sandell, E. B. Co1orimetrlp ,Determination 2! Traces 
or Metals, New York: Interseienee Publishers, 
".... , l! 
..Lnc., 19;)0. 
Sug1mura, T., Ono, T., and tJmeda, tr. "Distribution 
of Radioactive Iron Injeoted into Tumor-Bearing 
Animals," Gann, 48: 159, 1957. 
-54-
Photomicrograph 1 
Adenocarcinoma, breast 
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Photomicrograph 4 
Adenocarcinoma, colon 
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Photomicrograph 5 
Adenocarcinoma, rectum 
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Photomicrograph 6 
Adenocarcinoma, colon 
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Photomicrograph 7 
Adenocarcinoma, colon 
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Reagents 
1. Acetone 
2. Powdered Pure Iron 
3. Nitric Acid - 1:3 (25 ml. concentrated HNO) I 75 ml. distilled HOH) 
4. Hydrochloric Acid - 1:3 (25 mI. concentrated HCl I 75 mI. distilled HOH) 
5. Standard Iron Solution - concentration of 0.1 mg/m1 
a. 0.1 gm. of powdered pure iron dissolved by boiling 
in 50 m1. 1:3 RNO) and 50 ml. 1:3 HC1. Some 
material remained, probably ferric chloride, which 
diss10ved in distilled HOH. 
b. Dissolved iron diluted to one liter with distilled 
HOB. 
6. 25~ Trichloroacetic Acid • CC13COOB (25 gm. TCA I 100 ml. distilled BOB) 
7. 0.5~ a,a'.Dipyridyl - (2,2'.Bipyridine) 
(0.25 gm. I 50 ml. distilled HOB) 
a. Approxtmetely 3 m1. of 95~ ethyl alcohol should 
be used to dissolve the material before distilled 
HOH is added. 
8. Undiluted Thioglycolic Acid - (Mercaptoacetic Acid) -
HSCH2COOB 
9. 25~ Sodium Citrate - Na3C6Hs07.2H20 
(28.5 gm. / 100 ml. distilled HOR) 
25 sm. • x 
258.08 mol. wt. - '!!!'2~94"".~1~1~t-orm-.-wt"l"". 
x = 28.5 gm. 
10. 0.1 molar Sodium Oxalate 
(1.339 gm. I 100 ml. distilled HOn) 
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